Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Wollongong presents u-PA inhibitors

May 23, 2018

Sphingosine 1-phosphate receptor 5 agonists identified at AbbVie

May 23, 2018

Roche describes compounds for hepatitis B virus infection

May 23, 2018

Arbutus Biopharma, Protiva Biotherapeutics patent anti-HBV compounds

May 23, 2018

Biguanide derivative shows promise for prostate cancer therapy

May 23, 2018

Monoclonal antibodies shown to protect mice from EBOV infection

May 23, 2018

Cognition Therapeutics awarded NIH grants to further study lead candidate

May 23, 2018

Actavalon discovers anticancer compounds

May 23, 2018

Vast Therapeutics' BIOC-51 eradicates NTM in animal model

May 23, 2018

Nuclear receptor ROR-gamma inverse agonists disclosed by Escalier Biosciences

May 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...